Want to see HK:9939 full AI Analyst Report?
Kintor Pharmaceutical Ltd (9939) Financial Statements
Kintor Pharmaceutical Ltd Financial Overview
Kintor Pharmaceutical Ltd's market cap is currently $663.45M. The company's EPS TTM is $-0.41; its P/E ratio is -2.79; Kintor Pharmaceutical Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 32.68M | $ 5.00M | $ 0.00 | $ 0.00 | $ 34.23M |
| Gross Profit | $ 8.04M | $ -4.73M | $ -67.63M | $ -21.38M | $ 34.23M |
| Operating Income | $ -199.78M | $ -144.57M | $ -1.06B | $ -944.53M | $ -839.60M |
| EBITDA | $ -139.23M | $ -128.37M | $ -1.05B | $ -950.74M | $ -829.09M |
| Net Income | $ -200.11M | $ -155.29M | $ -1.06B | $ -954.37M | $ -842.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 34.78M | $ 148.69M | $ 455.50M | $ 875.08M | $ 1.06B |
| Total Assets | $ 340.95M | $ 515.13M | $ 869.23M | $ 2.06B | $ 2.07B |
| Total Debt | $ 86.64M | $ 133.01M | $ 253.92M | $ 286.39M | $ 159.73M |
| Net Debt | $ 51.85M | $ -14.41M | $ -191.58M | $ -578.70M | $ -770.42M |
| Total Liabilities | $ 158.28M | $ 221.05M | $ 411.12M | $ 559.95M | $ 412.83M |
| Stockholders' Equity | $ 182.67M | $ 294.08M | $ 458.11M | $ 1.50B | $ 1.66B |
| Cash Flow | |||||
| Free Cash Flow | $ -166.07M | $ -200.76M | $ -390.30M | $ -988.73K | $ -1.13M |
| Operating Cash Flow | $ -165.34M | $ -199.08M | $ -387.58M | $ -961.26K | $ -1.05M |
| Investing Cash Flow | $ 14.04M | $ 20.03M | $ 3.27M | $ 67.19K | $ 92.00K |
| Financing Cash Flow | $ 39.23M | $ -119.67M | $ -33.46M | $ 815.75K | $ 857.42K |
Currency in CNY
